
Neural Therapeutics Confirms Shareholder Vote for Hanf.com Acquisition Amidst Revenue Growth and Margin Compression
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE